Researchers Develop Tech to Detect Active Tuberculosis Easily
A research team discovered new technology that will quickly and easily detect active Mycobacterium tuberculosis (TB) infection antibodies.
Read MorePosted by Andy Lundin | Mar 13, 2023 | Hematology & Serology, Tuberculosis |
A research team discovered new technology that will quickly and easily detect active Mycobacterium tuberculosis (TB) infection antibodies.
Read MorePosted by Andy Lundin | Mar 10, 2023 | Leukemia |
QIAGEN and Servier are partnering to develop a CDx test for TIBSOVO, an isocitrate dehydrogenase-1 inhibitor indicated for AML treatment.
Read MorePosted by Chris Wolski | Feb 16, 2023 | Computing Systems, Middleware & Software |
There’s no hard and fast rules, but following these seven best practices, you can make your LIMS/LIS implementation a success.
Read MorePosted by Andy Lundin | Jan 31, 2023 | Immunoassay Reagents & test Kits, Infectious Diseases |
Beckman Coulter and MeMed are developing a diagnostic assay able to distinguish between bacterial and viral infections.
Read MorePosted by Andy Lundin | Jan 6, 2023 | Hematology & Serology |
Precision BioLogic announced FDA 510(k) clearance and the launch of its new CRYOcheck Chromogenic Factor IX assay in the U.S.
Read More